IRIS
PREZIOSA, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.441
NA - Nord America 2.785
EU - Europa 1.665
SA - Sud America 1.047
AF - Africa 108
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.062
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.654
SG - Singapore 1.866
CN - Cina 1.168
BR - Brasile 858
HK - Hong Kong 700
IT - Italia 413
SE - Svezia 356
VN - Vietnam 301
DE - Germania 240
RU - Federazione Russa 157
GB - Regno Unito 100
FI - Finlandia 93
IN - India 81
AR - Argentina 76
MX - Messico 60
IR - Iran 59
CA - Canada 55
FR - Francia 49
TR - Turchia 46
PL - Polonia 43
ZA - Sudafrica 42
NL - Olanda 41
AT - Austria 39
ES - Italia 37
JP - Giappone 36
EC - Ecuador 34
BD - Bangladesh 31
SA - Arabia Saudita 26
ID - Indonesia 24
EG - Egitto 22
IQ - Iraq 22
IE - Irlanda 21
VE - Venezuela 19
CO - Colombia 17
MA - Marocco 17
BE - Belgio 15
LT - Lituania 15
PY - Paraguay 15
PT - Portogallo 14
CL - Cile 11
AU - Australia 10
UZ - Uzbekistan 10
PE - Perù 9
PK - Pakistan 9
UA - Ucraina 9
IL - Israele 8
KE - Kenya 8
AE - Emirati Arabi Uniti 7
HN - Honduras 6
KR - Corea 6
AZ - Azerbaigian 5
CH - Svizzera 5
CY - Cipro 5
NG - Nigeria 5
NO - Norvegia 5
TN - Tunisia 5
TW - Taiwan 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
AO - Angola 3
NZ - Nuova Zelanda 3
AL - Albania 2
BO - Bolivia 2
DZ - Algeria 2
EU - Europa 2
PA - Panama 2
RO - Romania 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TC - Turks e Caicos 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.062
Salva come PNG Salva come JPEG
Città #
Dallas 959
Singapore 855
Hong Kong 681
Ashburn 333
Hefei 250
Beijing 240
Shanghai 216
Milan 118
Ho Chi Minh City 112
New York 100
Princeton 97
Lawrence 96
Los Angeles 92
Munich 88
São Paulo 84
Boardman 68
Hanoi 65
Moscow 63
Helsinki 56
Nuremberg 43
Rome 37
Rio de Janeiro 35
Mexico City 34
Chennai 31
Warsaw 31
Denver 29
Tokyo 29
Santa Clara 28
Poplar 25
Cesano Boscone 24
Boston 23
Johannesburg 23
Brooklyn 22
Stockholm 22
Ankara 21
Belo Horizonte 21
The Dalles 21
Dublin 20
Tehran 20
Turku 20
Frankfurt am Main 19
Montreal 19
Phoenix 19
Chicago 18
Guangzhou 18
Houston 18
Atlanta 17
Curitiba 17
Istanbul 16
Manchester 16
Vienna 16
Brasília 15
Lappeenranta 15
Radebeul 15
Shenzhen 15
Da Nang 14
London 14
Cairo 13
Washington 13
Amsterdam 12
Haiphong 12
Orem 12
Tianjin 12
Biên Hòa 11
Brussels 11
Mumbai 11
Seattle 11
Toronto 11
Buenos Aires 10
Campinas 10
Charlotte 10
Paris 10
Quito 10
Asunción 9
Erbil 9
Falkenstein 9
Guayaquil 9
New Delhi 9
Porto Alegre 9
Riyadh 9
Assago 8
Columbus 8
Dhaka 8
Genoa 8
Guarulhos 8
Hải Dương 8
Palermo 8
Tashkent 8
Baghdad 7
Bauru 7
Calgary 7
Hangzhou 7
Jeddah 7
Lima 7
Mauá 7
Ninh Bình 7
Pisa 7
Pittsburgh 7
Romagnano Sesia 7
San Francisco 7
Totale 5.803
Salva come PNG Salva come JPEG
Nome #
Erratum to: Multiple sclerosis (Nature Reviews Disease Primers, (2018), 4, 1, (43), 10.1038/s41572-018-0041-4) 306
Impact of Multiple Sclerosis on Cognitive Aging: A Multicenter Study 136
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 136
Dynamic functional connectivity of thalamic sub-regions shows divegent patterns in multiple sclerosis phenotypes 128
Gray matter damage predicts the accumulation of disability 13 years later in MS. 118
A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging 117
Voxel-wise multimodal MRI reveals specific patterns of brain damage in the main multiple sclerosis phenotypes 104
Cognitive Reserve Modulates the Impact of Structural Damage of the Frontal Lobe on Executive Functioning in Multiple Sclerosis (P1-1.Virtual) 99
Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability 99
Correspondence among gray matter atrophy and atlas-based neurotransmitter maps is clinically relevant in multiple sclerosis 98
Choroid plexus enlargement in paediatric multiple sclerosis: clinical relevance and effect of sex 85
Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study 83
Ocrelizumab extended-interval dosing in multiple sclerosis during SARS-CoV-2 pandemic: a real-world experience 81
Resting State Functional Connectivity Correlates of Executive Function in Patients with Multiple Sclerosis 81
In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI 80
Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression 75
Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis 74
Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap 73
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 73
Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis 70
Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study 69
A semiautomatic method for multiple sclerosis lesion segmentation on dual-echo MR imaging: application in a multicenter context 68
Functional and structural MRI correlates of executive functions in multiple sclerosis 66
In vivo quantification of brain soma and neurite density abnormalities in multiple sclerosis 64
Sex hormone-related factors and the risk of PIRA in women with multiple sclerosis 63
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 63
Regional white matter and gray matter damage and cognitive performances in multiple sclerosis according to sex 62
Diagnosis of Progressive Multiple Sclerosis from the Imaging Perspective: A Review 62
Association between pathological and MRI findings in multiple sclerosis 62
Action observation training modifies brain gray matter structure in healthy adult individuals 61
Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19? 61
Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study 61
Clinical Relevance of Multiparametric MRI Assessment of Cervical Cord Damage in Multiple Sclerosis 59
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives 59
Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis 59
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series 58
Amyloid-β, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer's disease 58
Machine learning-driven diagnosis of multiple sclerosis from whole blood transcriptomics 57
Dynamics of choroid plexus volume is associated with the presence and development of fatigue in multiple sclerosis 57
Cross-modal plasticity among sensory networks in neuromyelitis optica spectrum disorders 57
Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives 57
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis 56
What role should spinal cord MRI take in the future of multiple sclerosis surveillance? 56
Action observation training promotes motor improvement and modulates functional network dynamic connectivity in multiple sclerosis 56
Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis 55
Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study 55
Spatial correspondence among regional gene expressions and gray matter volume loss in multiple sclerosis 54
Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis 54
Brain and cervical spinal cord MRI correlates of sensorimotor impairment in patients with multiple sclerosis 53
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 53
Advances in neuroimaging of multiple sclerosis 53
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? 53
Chronic Active Lesions and Larger Choroid Plexus Explain Cognition and Fatigue in Multiple Sclerosis 52
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 52
Pediatric multiple sclerosis: developments in timely diagnosis and prognostication 52
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis 51
Neuromyelitis optica spectrum disorder and multiple sclerosis in a Sardinian family 51
Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex 51
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 50
Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients 50
Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study 50
The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis 49
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein–immunoglobulin G-associated Disease 49
A demyelinating disorder characterized by repeated episodes of optic neuritis and brainstem dysfuntions in a girl with anti-MOG positivity 49
Application of DIR and DT MRI to quantify focal and diffuse cortical damage in MS. 49
Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR Study 49
Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis 49
Central vein sign and iron rim in multiple sclerosis: ready for clinical use? 49
Clinically isolated syndromes suggestive of multiple sclerosis: dynamic patterns of gray and white matter changes - a 2 year MR imaging study 49
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis 49
Clinical relevance of spatial correspondence between regional gene expression and grey matter atrophy in multiple sclerosis 48
MRI of Transcallosal White Matter Helps to Predict Motor Impairment in Multiple Sclerosis 48
Sex-related differences in upper limb motor function in healthy subjects and multiple sclerosis patients: a multiparametric MRI study 48
Subventricular Zone Microstructure in Pediatric-Onset Multiple Sclerosis 48
Brain mapping in multiple sclerosis: Lessons learned about the human brain 47
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis 47
Human functional MRI 46
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study 46
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines 46
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple Sclerosis 46
Can post-mortem MRI be used as a proxy for in vivo? A case study 45
Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study 45
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 45
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 45
Brain reserve against physical disability progression over five years in multiple sclerosis 44
Quantitative MRI adds to neuropsychiatric lupus diagnostics 44
Different CSF-in gradients of damage occur in the thalamus, caudate nucleus and cortex in multiple sclerosis: a 3T magnetization transfer ratio and R2*study 43
Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective 43
Current state-of-art of the application of serum neurofilaments in multiple sclerosis diagnosis and monitoring 43
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis 42
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 42
Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis 42
The current role of MRI in differentiating multiple sclerosis from its imaging mimics 42
Age Matters in Multiple Sclerosis: Novel Insights Into Disease Progression From Clinical Onset 41
Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study 41
Identifying Progression in Multiple Sclerosis: New Perspectives 41
Paramagnetic rim and core sign lesions in paediatric multiple sclerosis patients 40
Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study 40
Effect of cognitive reserve on structural and functional MRI measures in healthy subjects: a multiparametric assessment 40
Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression 40
Totale 6.215
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.790
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 16 4 1 7 2 5 1
2021/2022130 1 4 5 40 2 10 11 19 15 7 9 7
2022/2023737 225 116 57 8 21 79 25 42 66 31 20 47
2023/2024725 32 46 52 111 65 81 59 68 9 53 49 100
2024/20253.468 250 97 102 85 124 183 256 357 688 568 287 471
2025/20265.416 914 948 1.052 1.608 839 55 0 0 0 0 0 0
Totale 10.585